Microbial isolates and their antimicrobial susceptibilities in inframalleolar foot infections

Surgical Infections

Volumn 15, Issue 5, 2014, Pages 585-591

  Barshes, Neal R ^a   Rodriguez Barradas, Maria C ^b   Bechara, Carlos F ^a   Pisimisis, George ^a   Young, Edward J ^b   Kougias, Panos ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CLINDAMYCIN; COTRIMOXAZOLE; ERTAPENEM; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; METICILLIN; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; STREPTOMYCIN; SULTAMICILLIN; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BONE; CLINICAL ARTICLE; DEBRIDEMENT; DIABETES MELLITUS; DISEASE SEVERITY; ENTEROCOCCUS; FEMALE; FOOT DISEASE; FOOT INFECTION; FOREFOOT; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION; INTRAOPERATIVE PERIOD; LIQUID; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL IDENTIFICATION; MICROORGANISM; MINIMUM INHIBITORY CONCENTRATION; SOFT TISSUE; STAPHYLOCOCCUS AUREUS; SURGICAL DRAINAGE; SURGICAL PATIENT; TOE; WOUND; BACTERIUM; CLASSIFICATION; DIABETIC FOOT; DRUG EFFECTS; FOOT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; SURGERY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; DIABETIC FOOT; FEMALE; FOOT; FOOT DISEASES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84912050633     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2013.126     Document Type: Article

References (8)

1. Gordois A, Scuffham P, Shearer A, et al. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 2003;26:1790-1795.
2. Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012;54:e132-173.
3. Schaper NC. Diabetic foot ulcer classification system for research purposes: A progress report on criteria for including patients in research studies. Diabetes Metab Res Rev 2004; 20(Suppl 1):S90-95.
4. Ge Y, MacDonald D, Hait H, et al. Microbiological profile of infected diabetic foot ulcers. Diabet Med 2002;19:1032-1034.
5. Acharya S, Soliman M, Egun A, et al. Conservative management of diabetic foot osteomyelitis. Diabetes Res Clin Pract 2013;101:e18-e20.
6. Aragón-Sánchez J, Lázaro-Martinez JL, Hernández-Herrero C, et al. Does osteomyelitis in the feet of patients with diabetes really recur after surgical treatment? Natural history of a surgical series. Diabet Med 2012;29:813-818.
7. Aragón-Sánchez J, Lázaro-Martínez JL, Quintana-Marrero Y, et al. Are diabetic foot ulcers complicated by MRSA osteomyelitis associated with worse prognosis? Outcomes of a surgical series. Diabet Med 2009;26:552-555.
8. Nather A, Bee CS, Huak CY, et al. Epidemiology of diabetic foot problems and predictive factors for limb loss. J Diabetes Complicat 2008;22:77-82.